Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
genskey logo — Empowering precision in pathogen diagnosis with advanced gen...

genskey

Empowering precision in pathogen diagnosis with advanced genetic testing technology, ensuring timely and accurate results for patients with severe infections.

Founded 2017 1 employees Series C Total: $437.12M Health Care

General Information

Company Name genskey
Founded Year 2017
Employees 1
Industries Health Care
Funding Stage Series C
Social

Get notified when genskey moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About genskey

GensKey is a health care startup founded in 2017. The company's mission revolves around empowering precision in pathogen diagnosis with advanced genetic testing technology, ensuring timely and accurate results for patients with severe infections. GensKey offers genetic testing medical diagnostics, utilizing high-throughput sequencing technology for pathogen identification. This innovative approach directly addresses challenges in detection rate, timeliness, and accuracy, ultimately ensuring timely and precise diagnoses for patients with severe infections. Notably, the company received a significant CNY100.00M Series C investment on 01 June 2021, with backing from Taikang Asset, CPE, and Oriza Seed Capital (Oriza Yuandian). This substantial investment stands as a testament to GensKey's promising potential and the confidence that prominent investors have in its groundbreaking approach to genetic testing for medical diagnostics.

Taxonomy: Genetic testing, Medical diagnostics, High-throughput sequencing technology, Pathogen identification, Precision medicine, Infectious diseases, Diagnostic accuracy

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 3
Investor Investor
•••• •••• 		01 Jun 2021
Series C •••••• 4
Investor Investor Investor
•••• •••• 		03 Nov 2020
Series B •••••• 2
Investor Investor
03 Feb 2020
Series B •••••• 1
Investor
18 Nov 2019
Series A •••••• - 01 Apr 2019

genskey Alternatives & Competitors

genskey vs
SMA Consulting Ltd.
SMA Consulting Ltd. Canada

Plan with confidence. Build with control.

38 employees
Analytics, Construction
genskey vs
Tool Testing Lab, Inc.
Tool Testing Lab, Inc. United States

Calibrate with Certainty. Buy with Confidence.

18 employees
genskey vs
Anchor Pointe Wealth Management
Anchor Pointe Wealth Management United States

Plan With Purpose...Live With Passion

4 employees
Financial Services, Wealth Management

FAQ About genskey

Empowering precision in pathogen diagnosis with advanced genetic testing technology, ensuring timely and accurate results for patients with severe infections.
genskey was founded in 2017.
genskey operates in the following industries: Health Care.
genskey has approximately 1 employees.
genskey has completed 5 funding rounds, raising a total of $437.12M. The latest funding stage is Series C.
Top alternatives and competitors to genskey include SMA Consulting Ltd., Tool Testing Lab, Inc., Anchor Pointe Wealth Management, Takamol Business Solutions, CorelDRAW Graphics Suite. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
genskey and SMA Consulting Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors genskey and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy